{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:53Z","timestamp":1792788773546,"version":"4.5.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","funder":[{"name":"NHLBI Division of Intramural Research","award":["K23HL150236"],"award-info":[{"award-number":["K23HL150236"]}],"id":[{"id":"https:\/\/ror.org\/023ny1p48","id-type":"ROR","asserted-by":"crossref"}]},{"name":"American Heart Association","id":[{"id":"https:\/\/ror.org\/013kjyp64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Heart, Lung, and Blood Institute","id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Heart failure and CKD often coexist. Heart failure with preserved ejection fraction (HFpEF) contributes to significant morbidity and mortality among patients with CKD. Among patients with CKD, along with traditional risk factors for heart failure, numerous CKD-specific pathophysiologic pathways contribute to the heightened risk of HFpEF development. However, the heterogeneity of HFpEF presents numerous challenges for diagnosis, treatment, and prevention, which has led to various phenotyping approaches. Phenotyping HFpEF may allow for better HFpEF characterization for targeted management and development of risk stratification strategies for prevention. In this Kidney Cross-Talk article, we discuss the epidemiology of HFpEF in CKD, pathways of HFpEF development in CKD, and highlight the impact of CKD in HFpEF phenotyping. In addition, we propose a potential risk-based prevention algorithm for heart failure among patients with CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000001013","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T17:00:44Z","timestamp":1769533244000},"page":"1847-1855","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Intersection of Heart Failure with Preserved Ejection Fraction and CKD"],"prefix":"10.2215","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7528-1991","authenticated-orcid":false,"given":"Vaishnavi","family":"Krishnan","sequence":"first","affiliation":[{"name":"Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-1859","authenticated-orcid":false,"given":"Sadiya S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-4325","authenticated-orcid":false,"given":"Rupal","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Division of Nephrology, Department of Medicine, Jesse Brown Veterans Administration Hospital System, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"10","key":"B1-20261009","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of death in patients with reduced kidney function","volume":"26","author":"Thompson","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B2-20261009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.amjmed.2024.09.002","article-title":"Heart failure mortality in chronic kidney disease: the fatal crossover","volume":"138","author":"Yeo","year":"2025","journal-title":"Am J Med."},{"issue":"20","key":"B3-20261009","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"issue":"20","key":"B4-20261009","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"issue":"8","key":"B5-20261009","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation."},{"issue":"4","key":"B6-20261009","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","article-title":"Forecasting the burden of cardiovascular disease and stroke in the United States through 2050-Prevalence of risk factors and disease: a presidential advisory from the American Heart Association","volume":"150","author":"Joynt Maddox","year":"2024","journal-title":"Circulation."},{"issue":"1","key":"B7-20261009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail."},{"issue":"4","key":"B8-20261009","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1161\/CIR.0000000000001258","article-title":"Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: a presidential advisory from the American Heart Association","volume":"150","author":"Kazi","year":"2024","journal-title":"Circulation."},{"issue":"1","key":"B9-20261009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation."},{"issue":"18","key":"B10-20261009","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol."},{"issue":"17","key":"B11-20261009","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/CIRCULATIONAHA.117.031622","article-title":"Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction","volume":"137","author":"Pandey","year":"2018","journal-title":"Circulation."},{"issue":"3","key":"B12-20261009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12265-017-9756-y","article-title":"Precision medicine for heart failure with preserved ejection fraction: an overview","volume":"10","author":"Shah","year":"2017","journal-title":"J Cardiovasc Transl Res."},{"issue":"1","key":"B13-20261009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation."},{"issue":"12","key":"B14-20261009","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","article-title":"Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute working group summary","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation."},{"issue":"5","key":"B15-20261009","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","article-title":"Mode of death in heart failure with preserved ejection fraction","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"9","key":"B16-20261009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4330\/wjc.v14.i9.473","article-title":"Thirty-day readmission in patients with heart failure with preserved ejection fraction: insights from the nationwide readmission database","volume":"14","author":"Jha","year":"2022","journal-title":"World J Cardiol."},{"issue":"5","key":"B17-20261009","doi-asserted-by":"crossref","first-page":"100624","DOI":"10.1016\/j.xkme.2023.100624","article-title":"All-cause and cardiovascular-related mortality in CKD patients with and without heart failure: a population-based cohort study in Kaiser Permanente Southern California","volume":"5","author":"Yu","year":"2023","journal-title":"Kidney Med."},{"issue":"5","key":"B18-20261009","doi-asserted-by":"crossref","first-page":"e011173","DOI":"10.1161\/CIRCHEARTFAILURE.123.011173","article-title":"Risk factors and outcomes associated with heart failure with preserved and reduced ejection fraction in people with chronic kidney disease","volume":"17","author":"Bansal","year":"2024","journal-title":"Circ Heart Fail."},{"issue":"12","key":"B19-20261009","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur J Heart Fail."},{"issue":"4","key":"B20-20261009","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B21-20261009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCOUTCOMES.113.000221","article-title":"Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the cardiovascular research network PRESERVE study","volume":"6","author":"Smith","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B22-20261009","doi-asserted-by":"crossref","first-page":"18-273","DOI":"10.7812\/TPP\/18.273","article-title":"Prognostic impact of chronic kidney disease in patients with heart failure","volume":"23","author":"Hakopian","year":"2019","journal-title":"Perm J."},{"issue":"1","key":"B23-20261009","doi-asserted-by":"crossref","first-page":"e000324","DOI":"10.1136\/openhrt-2015-000324","article-title":"Prevalence and prognostic impact of kidney disease on heart failure patients","volume":"3","author":"Lofman","year":"2016","journal-title":"Open Heart."},{"issue":"5","key":"B24-20261009","doi-asserted-by":"crossref","first-page":"622","DOI":"10.34067\/KID.0000000000000100","article-title":"Cardiac mechanics and kidney function decline in the cardiovascular health study","volume":"4","author":"Mehta","year":"2023","journal-title":"Kidney360."},{"issue":"12","key":"B25-20261009","doi-asserted-by":"crossref","first-page":"100705","DOI":"10.1016\/j.xkme.2023.100705","article-title":"Heart failure with preserved ejection fraction with CKD: a narrative review of a multispecialty disorder","volume":"5","author":"Patel","year":"2023","journal-title":"Kidney Med."},{"issue":"8","key":"B26-20261009","doi-asserted-by":"crossref","first-page":"102483","DOI":"10.1016\/j.jchf.2025.02.029","article-title":"Differential associations of cardiac, pulmonary, arterial, and muscle physiological parameters and biomarkers with the incidence of HFpEF and HFrEF","volume":"13","author":"Giugni","year":"2025","journal-title":"JACC Heart Fail."},{"issue":"1","key":"B27-20261009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamacardio.2024.4578","article-title":"Kidney outcomes in transthyretin amyloid cardiomyopathy","volume":"10","author":"Ioannou","year":"2025","journal-title":"JAMA Cardiol."},{"issue":"10","key":"B28-20261009","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy","volume":"128","author":"Marian","year":"2021","journal-title":"Circ Res."},{"issue":"21","key":"B29-20261009","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jama.2024.4467","article-title":"Cardiovascular burden of the V142I transthyretin variant","volume":"331","author":"Selvaraj","year":"2024","journal-title":"JAMA."},{"issue":"10","key":"B30-20261009","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jacc.2025.06.046","article-title":"Racial and ethnic differences in patient age at first hospitalization for heart failure","volume":"86","author":"Huang","year":"2025","journal-title":"J Am Coll Cardiol."},{"issue":"12","key":"B31-20261009","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","article-title":"Racial differences in incident heart failure among young adults","volume":"360","author":"Bibbins-Domingo","year":"2009","journal-title":"N Engl J Med."},{"issue":"2","key":"B32-20261009","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.125.325534","article-title":"Physiologic phenotyping of responses to exercise and activity in heart failure","volume":"137","author":"Lewis","year":"2025","journal-title":"Circ Res."},{"issue":"19","key":"B33-20261009","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","article-title":"Heart failure with preserved ejection fraction","volume":"375","author":"Redfield","year":"2016","journal-title":"N Engl J Med."},{"issue":"18","key":"B34-20261009","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1093\/cvr\/cvac179","article-title":"Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions","volume":"118","author":"Peters","year":"2023","journal-title":"Cardiovasc Res."},{"issue":"3","key":"B35-20261009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail."},{"issue":"1","key":"B36-20261009","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ejhf.1621","article-title":"Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis","volume":"22","author":"Segar","year":"2020","journal-title":"Eur J Heart Fail."},{"issue":"2","key":"B37-20261009","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCULATIONAHA.117.029058","article-title":"Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and ranking its causes using personalized O(2) pathway analysis","volume":"137","author":"Houstis","year":"2018","journal-title":"Circulation."},{"issue":"12","key":"B38-20261009","doi-asserted-by":"crossref","first-page":"102714","DOI":"10.1016\/j.jchf.2025.102714","article-title":"Rationale and design of the HeartShare\/AMP-HF deep phenotyping study to improve understanding of heart failure with preserved ejection fraction","volume":"13","author":"Borlaug","year":"2025","journal-title":"JACC Heart Fail."},{"issue":"1","key":"B39-20261009","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.445","article-title":"Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction","volume":"18","author":"Unger","year":"2016","journal-title":"Eur J Heart Fail."},{"issue":"10","key":"B40-20261009","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B41-20261009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cardfail.2010.08.009","article-title":"Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure","volume":"17","author":"Shlipak","year":"2011","journal-title":"J Card Fail."},{"issue":"4","key":"B42-20261009","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/CIRCHEARTFAILURE.115.002097","article-title":"Kansas City cardiomyopathy questionnaire score is associated with incident heart failure hospitalization in patients with chronic kidney disease without previously diagnosed heart failure: Chronic Renal Insufficiency Cohort study","volume":"8","author":"Mishra","year":"2015","journal-title":"Circ Heart Fail."},{"issue":"5","key":"B43-20261009","doi-asserted-by":"crossref","first-page":"101588","DOI":"10.1016\/j.rehab.2021.101588","article-title":"Cardiopulmonary reserve examined with cardiopulmonary exercise testing in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"65","author":"Pella","year":"2022","journal-title":"Ann Phys Rehabil Med."},{"issue":"3","key":"B44-20261009","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/ndt\/gfx064","article-title":"Early and asymptomatic cardiac dysfunction in chronic kidney disease","volume":"33","author":"Chinnappa","year":"2018","journal-title":"Nephrol Dial Transplant."},{"issue":"16","key":"B45-20261009","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1177\/2047487318777777","article-title":"Cardiopulmonary exercise testing reveals subclinical abnormalities in chronic kidney disease","volume":"25","author":"Kirkman","year":"2018","journal-title":"Eur J Prev Cardiol."},{"issue":"16","key":"B46-20261009","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation."},{"issue":"18","key":"B47-20261009","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation."},{"issue":"3","key":"B48-20261009","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the universal definition of heart failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail."},{"issue":"20","key":"B49-20261009","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1161\/CIR.0000000000001307","article-title":"Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association","volume":"151","author":"Khan","year":"2025","journal-title":"Circulation."},{"issue":"9","key":"B50-20261009","doi-asserted-by":"crossref","first-page":"102581","DOI":"10.1016\/j.jchf.2025.102581","article-title":"Heart failure in advanced chronic kidney disease: overlooked no more","volume":"13","author":"de la Espriella","year":"2025","journal-title":"JACC Heart Fail."},{"issue":"23","key":"B51-20261009","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2023.04.007","article-title":"Effect of 2022 ACC\/AHA\/HFSA criteria on stages of heart failure in a pooled community cohort","volume":"81","author":"Mohebi","year":"2023","journal-title":"J Am Coll Cardiol."},{"issue":"10508","key":"B52-20261009","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(25)01393-5","article-title":"Prioritising the primary prevention of heart failure","volume":"406","author":"Khan","year":"2025","journal-title":"Lancet."},{"issue":"9","key":"B53-20261009","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation."},{"issue":"8","key":"B54-20261009","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jchf.2020.03.013","article-title":"Application of diagnostic algorithms for heart failure with preserved ejection fraction to the community","volume":"8","author":"Selvaraj","year":"2020","journal-title":"JACC Heart Fail."},{"issue":"11","key":"B55-20261009","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"issue":"6","key":"B56-20261009","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation."},{"issue":"8","key":"B57-20261009","doi-asserted-by":"crossref","first-page":"102004","DOI":"10.1016\/j.jacadv.2025.102004","article-title":"Feasibility of the implementation of tools for heart failure risk prediction: a randomized controlled pilot trial","volume":"4","author":"Wang","year":"2025","journal-title":"JACC Adv."},{"issue":"4","key":"B58-20261009","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cardfail.2021.10.007","article-title":"Ten-year risk-prediction equations for incident heart failure hospitalizations in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort study and the multi-ethnic study of atherosclerosis","volume":"28","author":"Mehta","year":"2022","journal-title":"J Card Fail."},{"issue":"24","key":"B59-20261009","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation."},{"issue":"9","key":"B60-20261009","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2215\/CJN.0000000744","article-title":"The cardiovascular-kidney-metabolic health framework: implications for nephrology","volume":"20","author":"Rangaswami","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"15","key":"B61-20261009","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2023.2854","article-title":"Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial","volume":"329","author":"Pagidipati","year":"2023","journal-title":"JAMA."},{"issue":"1","key":"B62-20261009","first-page":"124","article-title":"Effect of a novel clinical decision support tool on the efficiency and accuracy of treatment recommendations for cholesterol management","volume":"8","author":"Scheitel","year":"2017","journal-title":"Appl Clin Inform."},{"issue":"4","key":"B63-20261009","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MLR.0b013e31818dce21","article-title":"Electronic health record-based cardiac risk assessment and identification of unmet preventive needs","volume":"47","author":"Persell","year":"2009","journal-title":"Med Care."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:17Z","timestamp":1791558077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000001013","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}